Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-115 |
Sentence |
denotes |
The effects of vitamin A supplementation with measles vaccine on leucocyte counts and in vitro cytokine production. |
T2 |
116-271 |
Sentence |
denotes |
As WHO recommends vitamin A supplementation (VAS) at vaccination contacts after age 6 months, many children receive VAS together with measles vaccine (MV). |
T3 |
272-342 |
Sentence |
denotes |
We aimed to investigate the immunological effect of VAS given with MV. |
T4 |
343-683 |
Sentence |
denotes |
Within a randomised placebo-controlled trial investigating the effect on overall mortality of providing VAS with vaccines in Guinea-Bissau, we conducted an immunological sub-study of VAS v. placebo with MV, analysing leucocyte counts, whole blood in vitro cytokine production, vitamin A status and concentration of C-reactive protein (CRP). |
T5 |
684-773 |
Sentence |
denotes |
VAS compared with placebo was associated with an increased frequency of CRP≥5 mg/l (28 v. |
T6 |
774-789 |
Sentence |
denotes |
12 %; P=0·005). |
T7 |
790-985 |
Sentence |
denotes |
Six weeks after supplementation, VAS had significant sex-differential effects on leucocyte, lymphocyte, monocyte and basophil cell counts, decreasing them in males but increasing them in females. |
T8 |
986-1261 |
Sentence |
denotes |
Mainly in females, the effect of VAS on cytokine responses differed by previous VAS: in previous VAS recipients, VAS increased the pro-inflammatory and T helper cell type 1 (Th1) cytokine responses, whereas VAS decreased these responses in previously unsupplemented children. |
T9 |
1262-1402 |
Sentence |
denotes |
In previous VAS recipients, VAS was associated with increased IFN-γ responses to phytohaemagglutinin in females (geometric mean ratio (GMR): |
T10 |
1403-1543 |
Sentence |
denotes |
3·97; 95 % CI 1·44, 10·90) but not in males (GMR 0·44; 95 % CI 0·14, 1·42); the opposite was observed in previously unsupplemented children. |
T11 |
1544-1662 |
Sentence |
denotes |
Our results corroborate that VAS provided with MV has immunological effects, which may depend on sex and previous VAS. |
T12 |
1663-1877 |
Sentence |
denotes |
VAS may increase the number of leucocytes, but also repress both the innate and lymphocyte-derived cytokine responses in females, whereas this repression may be opposite if the females have previously received VAS. |
T1 |
0-115 |
Sentence |
denotes |
The effects of vitamin A supplementation with measles vaccine on leucocyte counts and in vitro cytokine production. |
T2 |
116-271 |
Sentence |
denotes |
As WHO recommends vitamin A supplementation (VAS) at vaccination contacts after age 6 months, many children receive VAS together with measles vaccine (MV). |
T3 |
272-342 |
Sentence |
denotes |
We aimed to investigate the immunological effect of VAS given with MV. |
T4 |
343-683 |
Sentence |
denotes |
Within a randomised placebo-controlled trial investigating the effect on overall mortality of providing VAS with vaccines in Guinea-Bissau, we conducted an immunological sub-study of VAS v. placebo with MV, analysing leucocyte counts, whole blood in vitro cytokine production, vitamin A status and concentration of C-reactive protein (CRP). |
T5 |
684-773 |
Sentence |
denotes |
VAS compared with placebo was associated with an increased frequency of CRP≥5 mg/l (28 v. |
T6 |
774-789 |
Sentence |
denotes |
12 %; P=0·005). |
T7 |
790-985 |
Sentence |
denotes |
Six weeks after supplementation, VAS had significant sex-differential effects on leucocyte, lymphocyte, monocyte and basophil cell counts, decreasing them in males but increasing them in females. |
T8 |
986-1261 |
Sentence |
denotes |
Mainly in females, the effect of VAS on cytokine responses differed by previous VAS: in previous VAS recipients, VAS increased the pro-inflammatory and T helper cell type 1 (Th1) cytokine responses, whereas VAS decreased these responses in previously unsupplemented children. |
T9 |
1262-1402 |
Sentence |
denotes |
In previous VAS recipients, VAS was associated with increased IFN-γ responses to phytohaemagglutinin in females (geometric mean ratio (GMR): |
T10 |
1403-1543 |
Sentence |
denotes |
3·97; 95 % CI 1·44, 10·90) but not in males (GMR 0·44; 95 % CI 0·14, 1·42); the opposite was observed in previously unsupplemented children. |
T11 |
1544-1662 |
Sentence |
denotes |
Our results corroborate that VAS provided with MV has immunological effects, which may depend on sex and previous VAS. |
T12 |
1663-1877 |
Sentence |
denotes |
VAS may increase the number of leucocytes, but also repress both the innate and lymphocyte-derived cytokine responses in females, whereas this repression may be opposite if the females have previously received VAS. |